Publications by authors named "Ziting Ren"

Claim this Profile
M
miR-379-3p activates the MAPK/JNK/p38 pathway by negatively targeting DUSP1 expression to promote myocardial ischemia-reperfusion injury.
Wei Yang, Xiangfeng Bai, Yao Tang, Ziting Ren, Wendong Chen

Clin Hemorheol Microcirc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling.
Qun Zhao, Yun Bi, Jing Zhong, Ziting Ren, Yingxiang Liu

Toxicol Appl Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
Yingxiang Liu, Ziting Ren, Xiang Li, Jing Zhong, Yun Bi

Chem Biodivers· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo.
Qun Zhao, Yingxiang Liu, Jing Zhong, Yun Bi, Yongqiang Liu, Ziting Ren

Cell Death Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis